Financhill
Back

ADMA Biologics Quote, Financials, Valuation and Earnings

ADMA Biologics Price Quote

$16.24
-0.03 (-2.99%)
(Updated: September 7, 2024 at 6:19 AM ET)

ADMA Biologics Key Stats

Buy
69
ADMA Biologics (ADMA) is a Buy

Day range:
$16.07 - $16.94
52-week range:
$3.06 - $18.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.45
P/B ratio:
20.14%

Volume:
2.7M
Avg. volume:
3.8M
1-year change:
306.75%
Market cap:
$3.8B
Revenue:
$258.2M
EPS:
$0.14

How Much Does ADMA Biologics Make?

Is ADMA Biologics Growing As A Company?

  • What Is ADMA Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.78%
  • What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ADMA Biologics Stock Price Performance

  • Did ADMA Biologics Stock Go Up Last Month?
    ADMA Biologics share price went up by 37.18% last month
  • Did ADMA's Share Price Rise Over The Last Year?
    ADMA share price rose by 306.75% over the past 1 year

What Is ADMA Biologics 52-Week High & Low?

ADMA Biologics Price To Free Cash Flow

Is It Risky To Buy ADMA Biologics?

  • How Much Debt Does ADMA Biologics Have?
    Total long term debt quarterly is $131.1M
  • How Much Cash Does ADMA Biologics Have?
    Cash and short term investments quarterly total is $88.2M
  • What Is ADMA Biologics’s Book Value Per Share?
    Book value per share is 0.81

Is ADMA Biologics Cash Flow Positive?

  • What Is ADMA Cash Flow From Operations?
    Cash flow from operations (TTM) is $73M
  • What Is ADMA Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$40.4M
  • What Is ADMA Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.9M

ADMA Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADMA return on invested capital is 11.99%
  • What Is ADMA Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is 9.95%
  • What Is ADMA Return On Equity?
    ROE is a measure of profitability and is 22.43%

ADMA Biologics Earnings Date & Stock Price

ADMA Biologics Competitors

  • Who Are ADMA Biologics's Competitors?
    Below is a list of companies who compete with ADMA Biologics or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Perspective Therapeutics Inc (CATX)
    • Corcept Therapeutics Inc (CORT)
    • Ligand Pharmaceuticals Inc (LGND)
    • Regeneron Pharmaceuticals Inc (REGN)

ADMA Biologics Dividend Yield

ADMA Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 62.5%
Revenue: 78.29% 24.05%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.00
Upside from Last Price: 16.78%

Major Shareholders

  • How many ADMA shares are owned by institutional investors?
    283.2M ADMA shares are owned by institutional investors
  • How many ADMA shares are owned by insiders?
    4.7M ADMA shares are owned by insiders